1. Home
  2. QNCX vs MAXN Comparison

QNCX vs MAXN Comparison

Compare QNCX & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNCX
  • MAXN
  • Stock Information
  • Founded
  • QNCX 2012
  • MAXN 2019
  • Country
  • QNCX United States
  • MAXN Singapore
  • Employees
  • QNCX N/A
  • MAXN N/A
  • Industry
  • QNCX Biotechnology: Biological Products (No Diagnostic Substances)
  • MAXN Semiconductors
  • Sector
  • QNCX Health Care
  • MAXN Technology
  • Exchange
  • QNCX Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • QNCX 47.7M
  • MAXN 56.0M
  • IPO Year
  • QNCX 2019
  • MAXN N/A
  • Fundamental
  • Price
  • QNCX $1.68
  • MAXN $4.58
  • Analyst Decision
  • QNCX Strong Buy
  • MAXN Sell
  • Analyst Count
  • QNCX 5
  • MAXN 1
  • Target Price
  • QNCX $8.00
  • MAXN $4.00
  • AVG Volume (30 Days)
  • QNCX 235.8K
  • MAXN 210.5K
  • Earning Date
  • QNCX 08-12-2025
  • MAXN 09-02-2025
  • Dividend Yield
  • QNCX N/A
  • MAXN N/A
  • EPS Growth
  • QNCX N/A
  • MAXN N/A
  • EPS
  • QNCX N/A
  • MAXN N/A
  • Revenue
  • QNCX N/A
  • MAXN $509,048,000.00
  • Revenue This Year
  • QNCX N/A
  • MAXN $100.37
  • Revenue Next Year
  • QNCX N/A
  • MAXN $24.61
  • P/E Ratio
  • QNCX N/A
  • MAXN N/A
  • Revenue Growth
  • QNCX N/A
  • MAXN N/A
  • 52 Week Low
  • QNCX $0.51
  • MAXN $2.49
  • 52 Week High
  • QNCX $2.45
  • MAXN $23.11
  • Technical
  • Relative Strength Index (RSI)
  • QNCX 50.83
  • MAXN 64.55
  • Support Level
  • QNCX $1.75
  • MAXN $4.28
  • Resistance Level
  • QNCX $2.05
  • MAXN $4.97
  • Average True Range (ATR)
  • QNCX 0.16
  • MAXN 0.44
  • MACD
  • QNCX -0.02
  • MAXN 0.10
  • Stochastic Oscillator
  • QNCX 9.76
  • MAXN 77.97

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: